Slideshow
Author(s):
Authors of a new study found that patients who develop diabetes later in life have a higher risk of cardiovascular disease.
FDA Approves Merilog, Biosimilar Product of Insulin Aspart (Novolog) for Diabetes
Diabetes Dialogue: Omnipod 5 and Medtronic 780G for Type 2 Diabetes
Monlunabant Misses Primary Endpoint in Phase 2 Diabetic Kidney Disease Trial
Medical Ethics Unpacked: GLP-1 Allocation and Challenges of Equitable Access
Endocrinology Month in Review: January 2025
The HCPFive: Top News for Healthcare Providers from the Week of 1/26